942 related articles for article (PubMed ID: 26126706)
21. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
Thornton C; Johnson G; Agrawal S
J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
[TBL] [Abstract][Full Text] [Related]
22. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies.
Hadrich I; Mary C; Makni F; Elloumi M; Dumon H; Ayadi A; Ranque S
Med Mycol; 2011 Jul; 49(5):489-94. PubMed ID: 21108574
[TBL] [Abstract][Full Text] [Related]
23. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
24. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
Schwarzinger M; Sagaon-Teyssier L; Cabaret O; Bretagne S; Cordonnier C;
PLoS One; 2013; 8(6):e65776. PubMed ID: 23799048
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.
Buchheidt D; Baust C; Skladny H; Baldus M; Bräuninger S; Hehlmann R
Br J Haematol; 2002 Mar; 116(4):803-11. PubMed ID: 11886384
[TBL] [Abstract][Full Text] [Related]
26. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
[TBL] [Abstract][Full Text] [Related]
27. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
28. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
29. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
[TBL] [Abstract][Full Text] [Related]
30. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
31. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.
Suarez F; Lortholary O; Buland S; Rubio MT; Ghez D; Mahé V; Quesne G; Poirée S; Buzyn A; Varet B; Berche P; Bougnoux ME
J Clin Microbiol; 2008 Nov; 46(11):3772-7. PubMed ID: 18845828
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
36. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
McCulloch E; Ramage G; Rajendran R; Lappin DF; Jones B; Warn P; Shrief R; Kirkpatrick WR; Patterson TF; Williams C
J Clin Pathol; 2012 Jan; 65(1):83-6. PubMed ID: 22049217
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
38. Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.
de Kruif MD; Gerritsen MG; van Haren EH; Bel EH; Jonkers RE
Clin Respir J; 2017 Jul; 11(4):534-536. PubMed ID: 26364561
[No Abstract] [Full Text] [Related]
39. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
Shahid M; Malik A; Bhargava R
Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
[TBL] [Abstract][Full Text] [Related]
40. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
